View ValuationH&R GmbH KGaA 향후 성장Future 기준 점검 3/6H&R GmbH KGaA (는) 각각 연간 96.7% 및 4% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 96.6% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 1.4% 로 예상됩니다.핵심 정보96.7%이익 성장률96.61%EPS 성장률Chemicals 이익 성장43.2%매출 성장률4.0%향후 자기자본이익률1.41%애널리스트 커버리지Low마지막 업데이트03 Jul 2026최근 향후 성장 업데이트Price Target Changed • Jan 28Price target decreased by 13% to €4.50Down from €5.20, the current price target is an average from 2 analysts. New target price is 6.4% above last closing price of €4.23. Stock is up 13% over the past year. The company is forecast to post earnings per share of €0.08 for next year compared to €0.29 last year.Price Target Changed • May 11Price target decreased by 8.8% to €5.20Down from €5.70, the current price target is provided by 1 analyst. New target price is 31% above last closing price of €3.96. Stock is down 19% over the past year. The company is forecast to post earnings per share of €0.29 for next year compared to €0.29 last year.Major Estimate Revision • Oct 15Consensus revenue estimates fall by 12%The consensus outlook for revenues in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from €1.52b to €1.35b. EPS estimate fell from €0.39 to €0.25 per share. Net income forecast to grow 29% next year vs 59% growth forecast for Chemicals industry in Germany. Consensus price target up from €5.00 to €5.70. Share price was steady at €3.72 over the past week.Major Estimate Revision • Dec 20Consensus EPS estimates increase by 18%, revenue downgradedThe consensus outlook for fiscal year 2023 has been updated. 2023 revenue forecast fell from €1.32b to €1.27b. EPS estimate rose from €0.565 to €0.665. Net income forecast to grow 69% next year vs 16% growth forecast for Chemicals industry in Germany. Consensus price target of €6.50 unchanged from last update. Share price rose 11% to €4.80 over the past week.Major Estimate Revision • Nov 16Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 EPS estimate increased from €0.73 to €1.01. Revenue forecast unchanged at €1.57b. Net income forecast to shrink 48% next year vs 21% decline forecast for Chemicals industry in Germany. Consensus price target of €6.50 unchanged from last update. Share price was steady at €6.56 over the past week.Major Estimate Revision • Jul 27Consensus EPS estimates increase by 59%The consensus outlook for earnings per share (EPS) in 2022 has improved. 2022 revenue forecast increased from €1.54b to €1.57b. EPS estimate increased from €0.46 to €0.73 per share. Net income forecast to shrink 54% next year vs 4.5% decline forecast for Chemicals industry in Germany. Consensus price target of €7.25 unchanged from last update. Share price rose 6.0% to €6.40 over the past week.모든 업데이트 보기Recent updatesNew Risk • Jul 09New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 8.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite being loss-making. Share price has been volatile over the past 3 months (8.2% average weekly change).Reported Earnings • May 17First quarter 2026 earnings released: EPS: €0.10 (vs €0.05 in 1Q 2025)First quarter 2026 results: EPS: €0.10 (up from €0.05 in 1Q 2025). Revenue: €310.5m (down 10% from 1Q 2025). Net income: €3.90m (up 106% from 1Q 2025). Profit margin: 1.3% (up from 0.5% in 1Q 2025). Revenue is forecast to grow 5.4% p.a. on average during the next 3 years, compared to a 3.5% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 97 percentage points per year, which is a significant difference in performance.공고 • Apr 17H&R GmbH & Co. KGaA, Annual General Meeting, May 27, 2026H&R GmbH & Co. KGaA, Annual General Meeting, May 27, 2026, at 10:00 W. Europe Standard Time.Reported Earnings • Apr 06Full year 2025 earnings released: €1.04 loss per share (vs €0.28 profit in FY 2024)Full year 2025 results: €1.04 loss per share (down from €0.28 profit in FY 2024). Revenue: €1.28b (down 4.8% from FY 2024). Net loss: €38.8m (down 465% from profit in FY 2024). Revenue is forecast to grow 1.8% p.a. on average during the next 2 years, compared to a 3.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 78 percentage points per year, which is a significant difference in performance.Price Target Changed • Jan 28Price target decreased by 13% to €4.50Down from €5.20, the current price target is an average from 2 analysts. New target price is 6.4% above last closing price of €4.23. Stock is up 13% over the past year. The company is forecast to post earnings per share of €0.08 for next year compared to €0.29 last year.공고 • Dec 18+ 3 more updatesH&R GmbH & Co. KGaA to Report Q3, 2026 Results on Nov 13, 2026H&R GmbH & Co. KGaA announced that they will report Q3, 2026 results on Nov 13, 2026Reported Earnings • Nov 17Third quarter 2025 earnings released: €0.02 loss per share (vs €0.09 profit in 3Q 2024)Third quarter 2025 results: €0.02 loss per share (down from €0.09 profit in 3Q 2024). Revenue: €320.0m (down 5.3% from 3Q 2024). Net loss: €662.0k (down 119% from profit in 3Q 2024). Revenue is forecast to grow 2.1% p.a. on average during the next 3 years, compared to a 2.5% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 61 percentage points per year, which is a significant difference in performance.Reported Earnings • Aug 17Second quarter 2025 earnings released: €0.04 loss per share (vs €0.037 profit in 2Q 2024)Second quarter 2025 results: €0.04 loss per share (down from €0.037 profit in 2Q 2024). Revenue: €319.9m (down 3.6% from 2Q 2024). Net loss: €1.63m (down 226% from profit in 2Q 2024). Revenue is forecast to stay flat during the next 2 years compared to a 3.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 57 percentage points per year, which is a significant difference in performance.Upcoming Dividend • May 21Upcoming dividend of €0.10 per shareEligible shareholders must have bought the stock before 28 May 2025. Payment date: 30 May 2025. Payout ratio is a comfortable 34% and this is well supported by cash flows. Trailing yield: 2.0%. Lower than top quartile of German dividend payers (4.3%). Lower than average of industry peers (3.9%).분석 기사 • May 17There's No Escaping H&R GmbH & Co. KGaA's (ETR:2HRA) Muted Earnings Despite A 33% Share Price RiseH&R GmbH & Co. KGaA ( ETR:2HRA ) shares have continued their recent momentum with a 33% gain in the last month alone...Reported Earnings • May 16Full year 2024 earnings: EPS and revenues exceed analyst expectationsFull year 2024 results: EPS: €0.28 (up from €0.28 in FY 2023). Revenue: €1.35b (down 1.1% from FY 2023). Net income: €10.6m (flat on FY 2023). Profit margin: 0.8% (in line with FY 2023). Revenue exceeded analyst estimates by 3.4%. Earnings per share (EPS) also surpassed analyst estimates by 61%. Revenue is forecast to stay flat during the next 2 years compared to a 3.6% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 61 percentage points per year, which is a significant difference in performance.Valuation Update With 7 Day Price Move • May 16Investor sentiment improves as stock rises 26%After last week's 26% share price gain to €4.97, the stock trades at a trailing P/E ratio of 17.4x. Average forward P/E is 17x in the Chemicals industry in Germany. Total loss to shareholders of 8.3% over the past three years.Price Target Changed • May 11Price target decreased by 8.8% to €5.20Down from €5.70, the current price target is provided by 1 analyst. New target price is 31% above last closing price of €3.96. Stock is down 19% over the past year. The company is forecast to post earnings per share of €0.29 for next year compared to €0.29 last year.공고 • Apr 17H&R GmbH & Co. KGaA announces Annual dividend, payable on May 30, 2025H&R GmbH & Co. KGaA announced Annual dividend of EUR 0.1000 per share payable on May 30, 2025, ex-date on May 28, 2025 and record date on May 29, 2025.공고 • Apr 16H&R GmbH & Co. KGaA, Annual General Meeting, May 27, 2025H&R GmbH & Co. KGaA, Annual General Meeting, May 27, 2025, at 10:00 W. Europe Standard Time.Reported Earnings • Apr 10Full year 2024 earnings released: EPS: €0.29 (vs €0.28 in FY 2023)Full year 2024 results: EPS: €0.29 (up from €0.28 in FY 2023). Revenue: €1.38b (up 1.0% from FY 2023). Net income: €10.6m (flat on FY 2023). Profit margin: 0.8% (in line with FY 2023). Revenue is forecast to grow 1.9% p.a. on average during the next 2 years, compared to a 4.0% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 52 percentage points per year, which is a significant difference in performance.Valuation Update With 7 Day Price Move • Apr 08Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to €3.59, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 14x in the Chemicals industry in Germany. Total loss to shareholders of 35% over the past three years.분석 기사 • Mar 17Why Investors Shouldn't Be Surprised By H&R GmbH & Co. KGaA's (ETR:2HRA) 25% Share Price SurgeThe H&R GmbH & Co. KGaA ( ETR:2HRA ) share price has done very well over the last month, posting an excellent gain of...Valuation Update With 7 Day Price Move • Mar 17Investor sentiment improves as stock rises 16%After last week's 16% share price gain to €4.35, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 16x in the Chemicals industry in Germany. Total loss to shareholders of 33% over the past three years.공고 • Dec 13+ 3 more updatesH&R GmbH & Co. KGaA to Report Q3, 2025 Results on Nov 14, 2025H&R GmbH & Co. KGaA announced that they will report Q3, 2025 results on Nov 14, 2025Reported Earnings • Nov 17Third quarter 2024 earnings released: EPS: €0.09 (vs €0.20 in 3Q 2023)Third quarter 2024 results: EPS: €0.09 (down from €0.20 in 3Q 2023). Revenue: €348.7m (up 3.4% from 3Q 2023). Net income: €3.52m (down 54% from 3Q 2023). Profit margin: 1.0% (down from 2.2% in 3Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 2.7% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 61% per year but the company’s share price has only fallen by 25% per year, which means it has not declined as severely as earnings.분석 기사 • Oct 16This H&R GmbH & Co. KGaA (ETR:2HRA) Analyst Is Way More Bearish Than They Used To BeToday is shaping up negative for H&R GmbH & Co. KGaA ( ETR:2HRA ) shareholders, with the covering analyst delivering a...Major Estimate Revision • Oct 15Consensus revenue estimates fall by 12%The consensus outlook for revenues in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from €1.52b to €1.35b. EPS estimate fell from €0.39 to €0.25 per share. Net income forecast to grow 29% next year vs 59% growth forecast for Chemicals industry in Germany. Consensus price target up from €5.00 to €5.70. Share price was steady at €3.72 over the past week.Reported Earnings • Aug 16Second quarter 2024 earnings released: EPS: €0.03 (vs €0.13 in 2Q 2023)Second quarter 2024 results: EPS: €0.03 (down from €0.13 in 2Q 2023). Revenue: €347.5m (flat on 2Q 2023). Net income: €1.30m (down 72% from 2Q 2023). Profit margin: 0.4% (down from 1.3% in 2Q 2023). Revenue is forecast to grow 10% p.a. on average during the next 2 years, compared to a 4.5% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 47% per year but the company’s share price has only fallen by 27% per year, which means it has not declined as severely as earnings.Valuation Update With 7 Day Price Move • Jul 25Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to €4.14, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 13x in the Chemicals industry in Germany. Total loss to shareholders of 54% over the past three years.분석 기사 • Jul 24Returns On Capital At H&R GmbH KGaA (ETR:2HRA) Have StalledIf we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...Upcoming Dividend • May 22Upcoming dividend of €0.10 per shareEligible shareholders must have bought the stock before 29 May 2024. Payment date: 31 May 2024. Payout ratio is a comfortable 30% and this is well supported by cash flows. Trailing yield: 2.0%. Lower than top quartile of German dividend payers (4.6%). Lower than average of industry peers (5.0%).Reported Earnings • May 17First quarter 2024 earnings released: EPS: €0.04 (vs €0.03 loss in 1Q 2023)First quarter 2024 results: EPS: €0.04 (up from €0.03 loss in 1Q 2023). Revenue: €343.7m (down 1.5% from 1Q 2023). Net income: €1.47m (up €2.42m from 1Q 2023). Profit margin: 0.4% (up from net loss in 1Q 2023). The move to profitability was driven by lower expenses. Revenue is forecast to grow 8.9% p.a. on average during the next 2 years, compared to a 4.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings.분석 기사 • Apr 26H&R GmbH KGaA (ETR:2HRA) Is Paying Out A Dividend Of €0.10The board of H&R GmbH & Co. KGaA ( ETR:2HRA ) has announced that it will pay a dividend on the 31st of May, with...Reported Earnings • Mar 30Full year 2023 earnings: EPS and revenues miss analyst expectationsFull year 2023 results: EPS: €0.28 (down from €1.15 in FY 2022). Revenue: €1.35b (down 15% from FY 2022). Net income: €10.6m (down 75% from FY 2022). Profit margin: 0.8% (down from 2.7% in FY 2022). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 4.0%. Earnings per share (EPS) also missed analyst estimates by 40%. Revenue is forecast to grow 8.0% p.a. on average during the next 2 years, compared to a 3.8% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings.Declared Dividend • Mar 30Dividend of €0.10 announcedDividend of €0.10 is the same as last year. Ex-date: 29th May 2024 Payment date: 31st May 2024 Dividend yield will be 2.1%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is well covered by both earnings (36% earnings payout ratio) and cash flows (4% cash payout ratio). The dividend has decreased over the past 66 years, indicating a lack of growth and stability in payments. EPS is expected to grow by 53% over the next 2 years, which should provide support to the dividend and adequate earnings cover.공고 • Dec 21+ 4 more updatesH&R GmbH & Co. KGaA to Report Q2, 2024 Results on Aug 14, 2024H&R GmbH & Co. KGaA announced that they will report Q2, 2024 results on Aug 14, 2024분석 기사 • Dec 21Why H&R GmbH & Co. KGaA (ETR:2HRA) Could Be Worth WatchingH&R GmbH & Co. KGaA ( ETR:2HRA ), is not the largest company out there, but it saw a double-digit share price rise of...Major Estimate Revision • Dec 20Consensus EPS estimates increase by 18%, revenue downgradedThe consensus outlook for fiscal year 2023 has been updated. 2023 revenue forecast fell from €1.32b to €1.27b. EPS estimate rose from €0.565 to €0.665. Net income forecast to grow 69% next year vs 16% growth forecast for Chemicals industry in Germany. Consensus price target of €6.50 unchanged from last update. Share price rose 11% to €4.80 over the past week.Reported Earnings • Aug 18Second quarter 2023 earnings released: EPS: €0.13 (vs €0.58 in 2Q 2022)Second quarter 2023 results: EPS: €0.13 (down from €0.58 in 2Q 2022). Revenue: €358.1m (down 19% from 2Q 2022). Net income: €4.69m (down 78% from 2Q 2022). Profit margin: 1.3% (down from 4.9% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 1.8% p.a. on average during the next 3 years, compared to a 2.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 58% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.Upcoming Dividend • May 17Upcoming dividend of €0.10 per share at 1.9% yieldEligible shareholders must have bought the stock before 24 May 2023. Payment date: 26 May 2023. Trailing yield: 1.9%. Lower than top quartile of German dividend payers (4.7%). Lower than average of industry peers (5.6%).분석 기사 • Apr 29Is H&R GmbH KGaA (ETR:2HRA) Using Too Much Debt?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Valuation Update With 7 Day Price Move • Apr 27Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to €5.12, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 13x in the Chemicals industry in Germany. Total returns to shareholders of 24% over the past three years.Buying Opportunity • Apr 26Now 28% undervalued after recent price dropOver the last 90 days, the stock is down 9.6%. The fair value is estimated to be €7.59, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 18% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to decline by 13% in 2 years. Earnings is forecast to decline by 64% in the next 2 years.Buying Opportunity • Apr 04Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 2.5%. The fair value is estimated to be €7.76, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 18% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to decline by 12% in 2 years. Earnings is forecast to decline by 64% in the next 2 years.Reported Earnings • Apr 02Full year 2022 earnings: EPS exceeds analyst expectationsFull year 2022 results: EPS: €1.15 (down from €1.35 in FY 2021). Revenue: €1.58b (up 32% from FY 2021). Net income: €42.7m (down 15% from FY 2021). Profit margin: 2.7% (down from 4.2% in FY 2021). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 14%. Revenue is expected to decline by 6.7% p.a. on average during the next 2 years, while revenues in the Chemicals industry in Germany are expected to grow by 1.8%. Over the last 3 years on average, earnings per share has increased by 88% per year but the company’s share price has only increased by 18% per year, which means it is significantly lagging earnings growth.Buying Opportunity • Mar 01Now 22% undervalued after recent price dropOver the last 90 days, the stock is down 3.9%. The fair value is estimated to be €7.57, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Earnings per share has grown by 92%. Revenue is forecast to decline by 9.5% in 2 years. Earnings is forecast to decline by 65% in the next 2 years.Buying Opportunity • Feb 13Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 7.3%. The fair value is estimated to be €7.63, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Earnings per share has grown by 92%. Revenue is forecast to decline by 9.5% in 2 years. Earnings is forecast to decline by 65% in the next 2 years.Buying Opportunity • Jan 18Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 6.2%. The fair value is estimated to be €7.66, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Earnings per share has grown by 92%. Revenue is forecast to decline by 9.5% in 2 years. Earnings is forecast to decline by 65% in the next 2 years.공고 • Dec 21+ 4 more updatesH&R GmbH & Co. KGaA to Report Q2, 2023 Results on Aug 18, 2023H&R GmbH & Co. KGaA announced that they will report Q2, 2023 results on Aug 18, 2023Major Estimate Revision • Nov 16Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 EPS estimate increased from €0.73 to €1.01. Revenue forecast unchanged at €1.57b. Net income forecast to shrink 48% next year vs 21% decline forecast for Chemicals industry in Germany. Consensus price target of €6.50 unchanged from last update. Share price was steady at €6.56 over the past week.Reported Earnings • Aug 17Second quarter 2022 earnings released: EPS: €0.58 (vs €0.64 in 2Q 2021)Second quarter 2022 results: EPS: €0.58 (down from €0.64 in 2Q 2021). Revenue: €453.6m (up 43% from 2Q 2021). Net income: €21.6m (down 8.8% from 2Q 2021). Profit margin: 4.8% (down from 7.5% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 11%, compared to a 2.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 83% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.분석 기사 • Aug 09H&R GmbH KGaA (ETR:2HRA) Has More To Do To Multiply In Value Going ForwardTo find a multi-bagger stock, what are the underlying trends we should look for in a business? Ideally, a business will...Major Estimate Revision • Jul 27Consensus EPS estimates increase by 59%The consensus outlook for earnings per share (EPS) in 2022 has improved. 2022 revenue forecast increased from €1.54b to €1.57b. EPS estimate increased from €0.46 to €0.73 per share. Net income forecast to shrink 54% next year vs 4.5% decline forecast for Chemicals industry in Germany. Consensus price target of €7.25 unchanged from last update. Share price rose 6.0% to €6.40 over the past week.분석 기사 • Jul 19These 4 Measures Indicate That H&R GmbH KGaA (ETR:2HRA) Is Using Debt ExtensivelyThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Major Estimate Revision • May 20Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 revenue forecast increased from €1.39b to €1.54b. EPS estimate fell from €0.48 to €0.46. Net income forecast to shrink 71% next year vs 3.2% decline forecast for Chemicals industry in Germany. Consensus price target of €7.25 unchanged from last update. Share price fell 2.4% to €5.64 over the past week.Reported Earnings • May 16First quarter 2022 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2022 results: EPS: €0.22 (up from €0.19 in 1Q 2021). Revenue: €368.8m (up 53% from 1Q 2021). Net income: €8.09m (up 12% from 1Q 2021). Profit margin: 2.2% (down from 3.0% in 1Q 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 2.2%. Earnings per share (EPS) also surpassed analyst estimates by 3.8%. Over the next year, revenue is forecast to grow 6.7%, compared to a 6.4% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 68% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings.Price Target Changed • Apr 27Price target decreased to €7.25Down from €8.25, the current price target is provided by 1 analyst. New target price is 25% above last closing price of €5.82. Stock is down 21% over the past year. The company is forecast to post earnings per share of €0.48 for next year compared to €1.35 last year.Major Estimate Revision • Apr 08Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 revenue forecast increased from €1.21b to €1.39b. EPS estimate fell from €0.51 to €0.48. Net income forecast to shrink 65% next year vs 4.3% decline forecast for Chemicals industry in Germany. Consensus price target down from €8.50 to €7.25. Share price fell 5.3% to €5.70 over the past week.Reported Earnings • Apr 01Full year 2021 earnings: EPS and revenues exceed analyst expectationsFull year 2021 results: EPS: €1.35 (up from €0.24 loss in FY 2020). Revenue: €1.19b (up 35% from FY 2020). Net income: €50.2m (up €59.2m from FY 2020). Profit margin: 4.2% (up from net loss in FY 2020). The move to profitability was driven by higher revenue. Revenue exceeded analyst estimates by 2.2%. Earnings per share (EPS) also surpassed analyst estimates by 3.8%. Over the next year, revenue is forecast to grow 1.8%, compared to a 7.6% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 42% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings.분석 기사 • Mar 22H&R GmbH KGaA (ETR:2HRA) Has A Somewhat Strained Balance SheetHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Valuation Update With 7 Day Price Move • Feb 24Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to €5.84, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 10x in the Chemicals industry in Germany. Total loss to shareholders of 18% over the past three years.분석 기사 • Feb 22What Does H&R GmbH & Co. KGaA's (ETR:2HRA) Share Price Indicate?H&R GmbH & Co. KGaA ( ETR:2HRA ), is not the largest company out there, but it received a lot of attention from a...Valuation Update With 7 Day Price Move • Dec 02Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to €6.76, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 10x in the Chemicals industry in Germany. Total loss to shareholders of 4.0% over the past three years.분석 기사 • Nov 27H&R GmbH KGaA (ETR:2HRA) Takes On Some Risk With Its Use Of DebtHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Reported Earnings • Nov 17Third quarter 2021 earnings released: EPS €0.43 (vs €0.03 loss in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: €325.2m (up 56% from 3Q 2020). Net income: €16.0m (up €17.3m from 3Q 2020). Profit margin: 4.9% (up from net loss in 3Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 8% per year whereas the company’s share price has increased by 6% per year.Major Estimate Revision • Jul 23Consensus revenue estimates increase to €1.16bThe consensus outlook for revenues in 2021 has improved. 2021 revenue forecast increased from €1.01b to €1.16b. EPS estimate increased from €0.27 to €1.30 per share. Net income forecast to grow 1,239% next year vs 16% growth forecast for Chemicals industry in Germany. Consensus price target up from €8.50 to €11.00. Share price rose 11% to €9.34 over the past week.분석 기사 • Jul 22Is H&R GmbH KGaA (ETR:2HRA) A Risky Investment?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...분석 기사 • May 26The Returns On Capital At H&R GmbH KGaA (ETR:2HRA) Don't Inspire ConfidenceIf we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'll...Reported Earnings • May 17First quarter 2021 earnings released: EPS €0.19 (vs €0.13 loss in 1Q 2020)The company reported a decent first quarter result with improved earnings and profit margins, although revenues were weaker. First quarter 2021 results: Revenue: €248.5m (down 4.2% from 1Q 2020). Net income: €7.24m (up €12.0m from 1Q 2020). Profit margin: 2.9% (up from net loss in 1Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 82 percentage points per year, which is a significant difference in performance.분석 기사 • Apr 29H&R GmbH & Co. KGaA (ETR:2HRA) Shares Could Be 40% Below Their Intrinsic Value EstimateDoes the April share price for H&R GmbH & Co. KGaA ( ETR:2HRA ) reflect what it's really worth? Today, we will estimate...Reported Earnings • Apr 24Full year 2020 earnings released: €0.24 loss per share (vs €0.037 loss in FY 2019)The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2020 results: Revenue: €878.5m (down 19% from FY 2019). Net loss: €9.02m (loss widened €7.65m from FY 2019). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 89 percentage points per year, which is a significant difference in performance.분석 기사 • Mar 28H&R GmbH KGaA (ETR:2HRA) Has Debt But No Earnings; Should You Worry?David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...분석 기사 • Feb 04H&R GmbH KGaA's (ETR:2HRA) Shareholders Are Down 57% On Their SharesIt is a pleasure to report that the H&R GmbH & Co. KGaA ( ETR:2HRA ) is up 37% in the last quarter. But that is small...Price Target Changed • Feb 03Price target raised to €6.65Up from €5.90, the current price target is an average from 2 analysts. The new target price is 9.4% above the current share price of €6.08. As of last close, the stock is up 16% over the past year.Is New 90 Day High Low • Jan 21New 90-day high: €6.10The company is up 30% from its price of €4.71 on 23 October 2020. The German market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 22% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €1.12 per share.Is New 90 Day High Low • Jan 05New 90-day high: €5.75The company is up 14% from its price of €5.03 on 07 October 2020. The German market is up 8.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 16% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €1.10 per share.분석 기사 • Dec 13H&R GmbH KGaA (ETR:2HRA) Has Debt But No Earnings; Should You Worry?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Is New 90 Day High Low • Nov 27New 90-day high: €5.70The company is up 9.0% from its price of €5.22 on 28 August 2020. The German market is up 2.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 12% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €1.38 per share.Analyst Estimate Surprise Post Earnings • Nov 17Revenue and earnings miss expectationsRevenue missed analyst estimates by 16%. Earnings per share (EPS) were also behind analyst expectations. Over the next year, revenue is forecast to grow 5.7%, compared to a 3.6% growth forecast for the Chemicals industry in Germany.Reported Earnings • Nov 17Third quarter 2020 earnings released: €0.03 loss per shareThe company reported a decent third quarter result with reduced losses and improved control over expenses, although revenues were weaker. Third quarter 2020 results: Revenue: €213.3m (down 22% from 3Q 2019). Net loss: €1.21m (loss narrowed 80% from 3Q 2019). Over the last 3 years on average, earnings per share has fallen by 98% per year but the company’s share price has only fallen by 31% per year, which means it has not declined as severely as earnings.Is New 90 Day High Low • Oct 15New 90-day low: €4.84The company is down 19% from its price of €5.97 on 17 July 2020. The German market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 7.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €1.46 per share.공고 • Oct 05H&R Wasag AG to Report Fiscal Year 2009 Results on 03/30/2010H&R Wasag AG announced that they will report fiscal year 2009 results on 03/30/2010Is New 90 Day High Low • Sep 26New 90-day low: €5.14The company is down 1.0% from its price of €5.21 on 26 June 2020. The German market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €1.44 per share.이익 및 매출 성장 예측XTRA:2HRA - 애널리스트 향후 추정치 및 과거 재무 데이터 (EUR Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수12/31/20281,36110-471212/31/20271,3308-666212/31/20261,2946-165423/31/20261,207-3765125N/A12/31/20251,253-393392N/A9/30/20251,2984565N/A6/30/20251,32683789N/A3/31/20251,35711-451N/A12/31/20241,348101570N/A9/30/20241,34062271N/A6/30/20241,339101968N/A3/31/20241,344132982N/A12/31/20231,3631161119N/A9/30/20231,3971483149N/A6/30/20231,478172196N/A3/31/20231,579341891N/A12/31/20221,58543-3238N/A9/30/20221,54043-4615N/A6/30/20221,44149-1635N/A3/31/20221,31451-1737N/A12/31/20211,19350-1237N/A9/30/20211,10753-1629N/A6/30/202199536-1622N/A3/31/202186033253N/A12/31/2020879-92260N/A9/30/2020906-201169N/A6/30/2020973-251384N/A3/31/20201,054-11-2755N/A12/31/20191,081-1N/A96N/A9/30/20191,1125N/A85N/A6/30/20191,12017N/A90N/A3/31/20191,13617N/A70N/A12/31/20181,12122N/A23N/A9/30/20181,08018N/A11N/A6/30/20181,05426N/A21N/A3/31/20181,03532N/A44N/A12/31/20171,03132N/A46N/A9/30/20171,02835N/A53N/A6/30/20171,01133N/A41N/A3/31/201798835N/A51N/A12/31/201694838N/A75N/A9/30/201692835N/A90N/A6/30/201692835N/A81N/A3/31/201695336N/A84N/A12/31/201598827N/A56N/A9/30/20151,02316N/A52N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: 2HRA 은 향후 3년 동안 수익을 낼 것으로 예상되며, 이는 절약률(1.9%)보다 빠른 성장으로 간주됩니다.수익 vs 시장: 2HRA (는) 향후 3년 동안 평균 시장 성장보다 높은 수익을 올릴 것으로 예상됩니다.고성장 수익: 2HRA 향후 3년 내에 수익을 낼 것으로 예상됩니다.수익 대 시장: 2HRA 의 수익(연간 4%)이 German 시장(연간 6.6%)보다 느리게 성장할 것으로 예상됩니다.고성장 매출: 2HRA 의 수익(연간 4%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: 2HRA의 자본 수익률은 3년 후 1.4%로 낮을 것으로 예상됩니다.성장 기업 찾아보기7D1Y7D1Y7D1YMaterials 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/07/13 09:21종가2026/07/13 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스H&R GmbH & Co. KGaA는 7명의 분석가가 다루고 있습니다. 이 중 2명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Volker BosseBaader Helvea Equity ResearchAlexandra RocheBerenbergJesko Mayer-WegelinHSBC4명의 분석가 더 보기
Price Target Changed • Jan 28Price target decreased by 13% to €4.50Down from €5.20, the current price target is an average from 2 analysts. New target price is 6.4% above last closing price of €4.23. Stock is up 13% over the past year. The company is forecast to post earnings per share of €0.08 for next year compared to €0.29 last year.
Price Target Changed • May 11Price target decreased by 8.8% to €5.20Down from €5.70, the current price target is provided by 1 analyst. New target price is 31% above last closing price of €3.96. Stock is down 19% over the past year. The company is forecast to post earnings per share of €0.29 for next year compared to €0.29 last year.
Major Estimate Revision • Oct 15Consensus revenue estimates fall by 12%The consensus outlook for revenues in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from €1.52b to €1.35b. EPS estimate fell from €0.39 to €0.25 per share. Net income forecast to grow 29% next year vs 59% growth forecast for Chemicals industry in Germany. Consensus price target up from €5.00 to €5.70. Share price was steady at €3.72 over the past week.
Major Estimate Revision • Dec 20Consensus EPS estimates increase by 18%, revenue downgradedThe consensus outlook for fiscal year 2023 has been updated. 2023 revenue forecast fell from €1.32b to €1.27b. EPS estimate rose from €0.565 to €0.665. Net income forecast to grow 69% next year vs 16% growth forecast for Chemicals industry in Germany. Consensus price target of €6.50 unchanged from last update. Share price rose 11% to €4.80 over the past week.
Major Estimate Revision • Nov 16Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 EPS estimate increased from €0.73 to €1.01. Revenue forecast unchanged at €1.57b. Net income forecast to shrink 48% next year vs 21% decline forecast for Chemicals industry in Germany. Consensus price target of €6.50 unchanged from last update. Share price was steady at €6.56 over the past week.
Major Estimate Revision • Jul 27Consensus EPS estimates increase by 59%The consensus outlook for earnings per share (EPS) in 2022 has improved. 2022 revenue forecast increased from €1.54b to €1.57b. EPS estimate increased from €0.46 to €0.73 per share. Net income forecast to shrink 54% next year vs 4.5% decline forecast for Chemicals industry in Germany. Consensus price target of €7.25 unchanged from last update. Share price rose 6.0% to €6.40 over the past week.
New Risk • Jul 09New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 8.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite being loss-making. Share price has been volatile over the past 3 months (8.2% average weekly change).
Reported Earnings • May 17First quarter 2026 earnings released: EPS: €0.10 (vs €0.05 in 1Q 2025)First quarter 2026 results: EPS: €0.10 (up from €0.05 in 1Q 2025). Revenue: €310.5m (down 10% from 1Q 2025). Net income: €3.90m (up 106% from 1Q 2025). Profit margin: 1.3% (up from 0.5% in 1Q 2025). Revenue is forecast to grow 5.4% p.a. on average during the next 3 years, compared to a 3.5% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 97 percentage points per year, which is a significant difference in performance.
공고 • Apr 17H&R GmbH & Co. KGaA, Annual General Meeting, May 27, 2026H&R GmbH & Co. KGaA, Annual General Meeting, May 27, 2026, at 10:00 W. Europe Standard Time.
Reported Earnings • Apr 06Full year 2025 earnings released: €1.04 loss per share (vs €0.28 profit in FY 2024)Full year 2025 results: €1.04 loss per share (down from €0.28 profit in FY 2024). Revenue: €1.28b (down 4.8% from FY 2024). Net loss: €38.8m (down 465% from profit in FY 2024). Revenue is forecast to grow 1.8% p.a. on average during the next 2 years, compared to a 3.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 78 percentage points per year, which is a significant difference in performance.
Price Target Changed • Jan 28Price target decreased by 13% to €4.50Down from €5.20, the current price target is an average from 2 analysts. New target price is 6.4% above last closing price of €4.23. Stock is up 13% over the past year. The company is forecast to post earnings per share of €0.08 for next year compared to €0.29 last year.
공고 • Dec 18+ 3 more updatesH&R GmbH & Co. KGaA to Report Q3, 2026 Results on Nov 13, 2026H&R GmbH & Co. KGaA announced that they will report Q3, 2026 results on Nov 13, 2026
Reported Earnings • Nov 17Third quarter 2025 earnings released: €0.02 loss per share (vs €0.09 profit in 3Q 2024)Third quarter 2025 results: €0.02 loss per share (down from €0.09 profit in 3Q 2024). Revenue: €320.0m (down 5.3% from 3Q 2024). Net loss: €662.0k (down 119% from profit in 3Q 2024). Revenue is forecast to grow 2.1% p.a. on average during the next 3 years, compared to a 2.5% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 61 percentage points per year, which is a significant difference in performance.
Reported Earnings • Aug 17Second quarter 2025 earnings released: €0.04 loss per share (vs €0.037 profit in 2Q 2024)Second quarter 2025 results: €0.04 loss per share (down from €0.037 profit in 2Q 2024). Revenue: €319.9m (down 3.6% from 2Q 2024). Net loss: €1.63m (down 226% from profit in 2Q 2024). Revenue is forecast to stay flat during the next 2 years compared to a 3.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 57 percentage points per year, which is a significant difference in performance.
Upcoming Dividend • May 21Upcoming dividend of €0.10 per shareEligible shareholders must have bought the stock before 28 May 2025. Payment date: 30 May 2025. Payout ratio is a comfortable 34% and this is well supported by cash flows. Trailing yield: 2.0%. Lower than top quartile of German dividend payers (4.3%). Lower than average of industry peers (3.9%).
분석 기사 • May 17There's No Escaping H&R GmbH & Co. KGaA's (ETR:2HRA) Muted Earnings Despite A 33% Share Price RiseH&R GmbH & Co. KGaA ( ETR:2HRA ) shares have continued their recent momentum with a 33% gain in the last month alone...
Reported Earnings • May 16Full year 2024 earnings: EPS and revenues exceed analyst expectationsFull year 2024 results: EPS: €0.28 (up from €0.28 in FY 2023). Revenue: €1.35b (down 1.1% from FY 2023). Net income: €10.6m (flat on FY 2023). Profit margin: 0.8% (in line with FY 2023). Revenue exceeded analyst estimates by 3.4%. Earnings per share (EPS) also surpassed analyst estimates by 61%. Revenue is forecast to stay flat during the next 2 years compared to a 3.6% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 61 percentage points per year, which is a significant difference in performance.
Valuation Update With 7 Day Price Move • May 16Investor sentiment improves as stock rises 26%After last week's 26% share price gain to €4.97, the stock trades at a trailing P/E ratio of 17.4x. Average forward P/E is 17x in the Chemicals industry in Germany. Total loss to shareholders of 8.3% over the past three years.
Price Target Changed • May 11Price target decreased by 8.8% to €5.20Down from €5.70, the current price target is provided by 1 analyst. New target price is 31% above last closing price of €3.96. Stock is down 19% over the past year. The company is forecast to post earnings per share of €0.29 for next year compared to €0.29 last year.
공고 • Apr 17H&R GmbH & Co. KGaA announces Annual dividend, payable on May 30, 2025H&R GmbH & Co. KGaA announced Annual dividend of EUR 0.1000 per share payable on May 30, 2025, ex-date on May 28, 2025 and record date on May 29, 2025.
공고 • Apr 16H&R GmbH & Co. KGaA, Annual General Meeting, May 27, 2025H&R GmbH & Co. KGaA, Annual General Meeting, May 27, 2025, at 10:00 W. Europe Standard Time.
Reported Earnings • Apr 10Full year 2024 earnings released: EPS: €0.29 (vs €0.28 in FY 2023)Full year 2024 results: EPS: €0.29 (up from €0.28 in FY 2023). Revenue: €1.38b (up 1.0% from FY 2023). Net income: €10.6m (flat on FY 2023). Profit margin: 0.8% (in line with FY 2023). Revenue is forecast to grow 1.9% p.a. on average during the next 2 years, compared to a 4.0% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 52 percentage points per year, which is a significant difference in performance.
Valuation Update With 7 Day Price Move • Apr 08Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to €3.59, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 14x in the Chemicals industry in Germany. Total loss to shareholders of 35% over the past three years.
분석 기사 • Mar 17Why Investors Shouldn't Be Surprised By H&R GmbH & Co. KGaA's (ETR:2HRA) 25% Share Price SurgeThe H&R GmbH & Co. KGaA ( ETR:2HRA ) share price has done very well over the last month, posting an excellent gain of...
Valuation Update With 7 Day Price Move • Mar 17Investor sentiment improves as stock rises 16%After last week's 16% share price gain to €4.35, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 16x in the Chemicals industry in Germany. Total loss to shareholders of 33% over the past three years.
공고 • Dec 13+ 3 more updatesH&R GmbH & Co. KGaA to Report Q3, 2025 Results on Nov 14, 2025H&R GmbH & Co. KGaA announced that they will report Q3, 2025 results on Nov 14, 2025
Reported Earnings • Nov 17Third quarter 2024 earnings released: EPS: €0.09 (vs €0.20 in 3Q 2023)Third quarter 2024 results: EPS: €0.09 (down from €0.20 in 3Q 2023). Revenue: €348.7m (up 3.4% from 3Q 2023). Net income: €3.52m (down 54% from 3Q 2023). Profit margin: 1.0% (down from 2.2% in 3Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 2.7% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 61% per year but the company’s share price has only fallen by 25% per year, which means it has not declined as severely as earnings.
분석 기사 • Oct 16This H&R GmbH & Co. KGaA (ETR:2HRA) Analyst Is Way More Bearish Than They Used To BeToday is shaping up negative for H&R GmbH & Co. KGaA ( ETR:2HRA ) shareholders, with the covering analyst delivering a...
Major Estimate Revision • Oct 15Consensus revenue estimates fall by 12%The consensus outlook for revenues in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from €1.52b to €1.35b. EPS estimate fell from €0.39 to €0.25 per share. Net income forecast to grow 29% next year vs 59% growth forecast for Chemicals industry in Germany. Consensus price target up from €5.00 to €5.70. Share price was steady at €3.72 over the past week.
Reported Earnings • Aug 16Second quarter 2024 earnings released: EPS: €0.03 (vs €0.13 in 2Q 2023)Second quarter 2024 results: EPS: €0.03 (down from €0.13 in 2Q 2023). Revenue: €347.5m (flat on 2Q 2023). Net income: €1.30m (down 72% from 2Q 2023). Profit margin: 0.4% (down from 1.3% in 2Q 2023). Revenue is forecast to grow 10% p.a. on average during the next 2 years, compared to a 4.5% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 47% per year but the company’s share price has only fallen by 27% per year, which means it has not declined as severely as earnings.
Valuation Update With 7 Day Price Move • Jul 25Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to €4.14, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 13x in the Chemicals industry in Germany. Total loss to shareholders of 54% over the past three years.
분석 기사 • Jul 24Returns On Capital At H&R GmbH KGaA (ETR:2HRA) Have StalledIf we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
Upcoming Dividend • May 22Upcoming dividend of €0.10 per shareEligible shareholders must have bought the stock before 29 May 2024. Payment date: 31 May 2024. Payout ratio is a comfortable 30% and this is well supported by cash flows. Trailing yield: 2.0%. Lower than top quartile of German dividend payers (4.6%). Lower than average of industry peers (5.0%).
Reported Earnings • May 17First quarter 2024 earnings released: EPS: €0.04 (vs €0.03 loss in 1Q 2023)First quarter 2024 results: EPS: €0.04 (up from €0.03 loss in 1Q 2023). Revenue: €343.7m (down 1.5% from 1Q 2023). Net income: €1.47m (up €2.42m from 1Q 2023). Profit margin: 0.4% (up from net loss in 1Q 2023). The move to profitability was driven by lower expenses. Revenue is forecast to grow 8.9% p.a. on average during the next 2 years, compared to a 4.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings.
분석 기사 • Apr 26H&R GmbH KGaA (ETR:2HRA) Is Paying Out A Dividend Of €0.10The board of H&R GmbH & Co. KGaA ( ETR:2HRA ) has announced that it will pay a dividend on the 31st of May, with...
Reported Earnings • Mar 30Full year 2023 earnings: EPS and revenues miss analyst expectationsFull year 2023 results: EPS: €0.28 (down from €1.15 in FY 2022). Revenue: €1.35b (down 15% from FY 2022). Net income: €10.6m (down 75% from FY 2022). Profit margin: 0.8% (down from 2.7% in FY 2022). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 4.0%. Earnings per share (EPS) also missed analyst estimates by 40%. Revenue is forecast to grow 8.0% p.a. on average during the next 2 years, compared to a 3.8% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings.
Declared Dividend • Mar 30Dividend of €0.10 announcedDividend of €0.10 is the same as last year. Ex-date: 29th May 2024 Payment date: 31st May 2024 Dividend yield will be 2.1%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is well covered by both earnings (36% earnings payout ratio) and cash flows (4% cash payout ratio). The dividend has decreased over the past 66 years, indicating a lack of growth and stability in payments. EPS is expected to grow by 53% over the next 2 years, which should provide support to the dividend and adequate earnings cover.
공고 • Dec 21+ 4 more updatesH&R GmbH & Co. KGaA to Report Q2, 2024 Results on Aug 14, 2024H&R GmbH & Co. KGaA announced that they will report Q2, 2024 results on Aug 14, 2024
분석 기사 • Dec 21Why H&R GmbH & Co. KGaA (ETR:2HRA) Could Be Worth WatchingH&R GmbH & Co. KGaA ( ETR:2HRA ), is not the largest company out there, but it saw a double-digit share price rise of...
Major Estimate Revision • Dec 20Consensus EPS estimates increase by 18%, revenue downgradedThe consensus outlook for fiscal year 2023 has been updated. 2023 revenue forecast fell from €1.32b to €1.27b. EPS estimate rose from €0.565 to €0.665. Net income forecast to grow 69% next year vs 16% growth forecast for Chemicals industry in Germany. Consensus price target of €6.50 unchanged from last update. Share price rose 11% to €4.80 over the past week.
Reported Earnings • Aug 18Second quarter 2023 earnings released: EPS: €0.13 (vs €0.58 in 2Q 2022)Second quarter 2023 results: EPS: €0.13 (down from €0.58 in 2Q 2022). Revenue: €358.1m (down 19% from 2Q 2022). Net income: €4.69m (down 78% from 2Q 2022). Profit margin: 1.3% (down from 4.9% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 1.8% p.a. on average during the next 3 years, compared to a 2.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 58% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.
Upcoming Dividend • May 17Upcoming dividend of €0.10 per share at 1.9% yieldEligible shareholders must have bought the stock before 24 May 2023. Payment date: 26 May 2023. Trailing yield: 1.9%. Lower than top quartile of German dividend payers (4.7%). Lower than average of industry peers (5.6%).
분석 기사 • Apr 29Is H&R GmbH KGaA (ETR:2HRA) Using Too Much Debt?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Valuation Update With 7 Day Price Move • Apr 27Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to €5.12, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 13x in the Chemicals industry in Germany. Total returns to shareholders of 24% over the past three years.
Buying Opportunity • Apr 26Now 28% undervalued after recent price dropOver the last 90 days, the stock is down 9.6%. The fair value is estimated to be €7.59, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 18% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to decline by 13% in 2 years. Earnings is forecast to decline by 64% in the next 2 years.
Buying Opportunity • Apr 04Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 2.5%. The fair value is estimated to be €7.76, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 18% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to decline by 12% in 2 years. Earnings is forecast to decline by 64% in the next 2 years.
Reported Earnings • Apr 02Full year 2022 earnings: EPS exceeds analyst expectationsFull year 2022 results: EPS: €1.15 (down from €1.35 in FY 2021). Revenue: €1.58b (up 32% from FY 2021). Net income: €42.7m (down 15% from FY 2021). Profit margin: 2.7% (down from 4.2% in FY 2021). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 14%. Revenue is expected to decline by 6.7% p.a. on average during the next 2 years, while revenues in the Chemicals industry in Germany are expected to grow by 1.8%. Over the last 3 years on average, earnings per share has increased by 88% per year but the company’s share price has only increased by 18% per year, which means it is significantly lagging earnings growth.
Buying Opportunity • Mar 01Now 22% undervalued after recent price dropOver the last 90 days, the stock is down 3.9%. The fair value is estimated to be €7.57, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Earnings per share has grown by 92%. Revenue is forecast to decline by 9.5% in 2 years. Earnings is forecast to decline by 65% in the next 2 years.
Buying Opportunity • Feb 13Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 7.3%. The fair value is estimated to be €7.63, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Earnings per share has grown by 92%. Revenue is forecast to decline by 9.5% in 2 years. Earnings is forecast to decline by 65% in the next 2 years.
Buying Opportunity • Jan 18Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 6.2%. The fair value is estimated to be €7.66, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Earnings per share has grown by 92%. Revenue is forecast to decline by 9.5% in 2 years. Earnings is forecast to decline by 65% in the next 2 years.
공고 • Dec 21+ 4 more updatesH&R GmbH & Co. KGaA to Report Q2, 2023 Results on Aug 18, 2023H&R GmbH & Co. KGaA announced that they will report Q2, 2023 results on Aug 18, 2023
Major Estimate Revision • Nov 16Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 EPS estimate increased from €0.73 to €1.01. Revenue forecast unchanged at €1.57b. Net income forecast to shrink 48% next year vs 21% decline forecast for Chemicals industry in Germany. Consensus price target of €6.50 unchanged from last update. Share price was steady at €6.56 over the past week.
Reported Earnings • Aug 17Second quarter 2022 earnings released: EPS: €0.58 (vs €0.64 in 2Q 2021)Second quarter 2022 results: EPS: €0.58 (down from €0.64 in 2Q 2021). Revenue: €453.6m (up 43% from 2Q 2021). Net income: €21.6m (down 8.8% from 2Q 2021). Profit margin: 4.8% (down from 7.5% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 11%, compared to a 2.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 83% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.
분석 기사 • Aug 09H&R GmbH KGaA (ETR:2HRA) Has More To Do To Multiply In Value Going ForwardTo find a multi-bagger stock, what are the underlying trends we should look for in a business? Ideally, a business will...
Major Estimate Revision • Jul 27Consensus EPS estimates increase by 59%The consensus outlook for earnings per share (EPS) in 2022 has improved. 2022 revenue forecast increased from €1.54b to €1.57b. EPS estimate increased from €0.46 to €0.73 per share. Net income forecast to shrink 54% next year vs 4.5% decline forecast for Chemicals industry in Germany. Consensus price target of €7.25 unchanged from last update. Share price rose 6.0% to €6.40 over the past week.
분석 기사 • Jul 19These 4 Measures Indicate That H&R GmbH KGaA (ETR:2HRA) Is Using Debt ExtensivelyThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Major Estimate Revision • May 20Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 revenue forecast increased from €1.39b to €1.54b. EPS estimate fell from €0.48 to €0.46. Net income forecast to shrink 71% next year vs 3.2% decline forecast for Chemicals industry in Germany. Consensus price target of €7.25 unchanged from last update. Share price fell 2.4% to €5.64 over the past week.
Reported Earnings • May 16First quarter 2022 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2022 results: EPS: €0.22 (up from €0.19 in 1Q 2021). Revenue: €368.8m (up 53% from 1Q 2021). Net income: €8.09m (up 12% from 1Q 2021). Profit margin: 2.2% (down from 3.0% in 1Q 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 2.2%. Earnings per share (EPS) also surpassed analyst estimates by 3.8%. Over the next year, revenue is forecast to grow 6.7%, compared to a 6.4% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 68% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings.
Price Target Changed • Apr 27Price target decreased to €7.25Down from €8.25, the current price target is provided by 1 analyst. New target price is 25% above last closing price of €5.82. Stock is down 21% over the past year. The company is forecast to post earnings per share of €0.48 for next year compared to €1.35 last year.
Major Estimate Revision • Apr 08Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 revenue forecast increased from €1.21b to €1.39b. EPS estimate fell from €0.51 to €0.48. Net income forecast to shrink 65% next year vs 4.3% decline forecast for Chemicals industry in Germany. Consensus price target down from €8.50 to €7.25. Share price fell 5.3% to €5.70 over the past week.
Reported Earnings • Apr 01Full year 2021 earnings: EPS and revenues exceed analyst expectationsFull year 2021 results: EPS: €1.35 (up from €0.24 loss in FY 2020). Revenue: €1.19b (up 35% from FY 2020). Net income: €50.2m (up €59.2m from FY 2020). Profit margin: 4.2% (up from net loss in FY 2020). The move to profitability was driven by higher revenue. Revenue exceeded analyst estimates by 2.2%. Earnings per share (EPS) also surpassed analyst estimates by 3.8%. Over the next year, revenue is forecast to grow 1.8%, compared to a 7.6% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 42% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings.
분석 기사 • Mar 22H&R GmbH KGaA (ETR:2HRA) Has A Somewhat Strained Balance SheetHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Valuation Update With 7 Day Price Move • Feb 24Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to €5.84, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 10x in the Chemicals industry in Germany. Total loss to shareholders of 18% over the past three years.
분석 기사 • Feb 22What Does H&R GmbH & Co. KGaA's (ETR:2HRA) Share Price Indicate?H&R GmbH & Co. KGaA ( ETR:2HRA ), is not the largest company out there, but it received a lot of attention from a...
Valuation Update With 7 Day Price Move • Dec 02Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to €6.76, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 10x in the Chemicals industry in Germany. Total loss to shareholders of 4.0% over the past three years.
분석 기사 • Nov 27H&R GmbH KGaA (ETR:2HRA) Takes On Some Risk With Its Use Of DebtHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Reported Earnings • Nov 17Third quarter 2021 earnings released: EPS €0.43 (vs €0.03 loss in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: €325.2m (up 56% from 3Q 2020). Net income: €16.0m (up €17.3m from 3Q 2020). Profit margin: 4.9% (up from net loss in 3Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 8% per year whereas the company’s share price has increased by 6% per year.
Major Estimate Revision • Jul 23Consensus revenue estimates increase to €1.16bThe consensus outlook for revenues in 2021 has improved. 2021 revenue forecast increased from €1.01b to €1.16b. EPS estimate increased from €0.27 to €1.30 per share. Net income forecast to grow 1,239% next year vs 16% growth forecast for Chemicals industry in Germany. Consensus price target up from €8.50 to €11.00. Share price rose 11% to €9.34 over the past week.
분석 기사 • Jul 22Is H&R GmbH KGaA (ETR:2HRA) A Risky Investment?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
분석 기사 • May 26The Returns On Capital At H&R GmbH KGaA (ETR:2HRA) Don't Inspire ConfidenceIf we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'll...
Reported Earnings • May 17First quarter 2021 earnings released: EPS €0.19 (vs €0.13 loss in 1Q 2020)The company reported a decent first quarter result with improved earnings and profit margins, although revenues were weaker. First quarter 2021 results: Revenue: €248.5m (down 4.2% from 1Q 2020). Net income: €7.24m (up €12.0m from 1Q 2020). Profit margin: 2.9% (up from net loss in 1Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 82 percentage points per year, which is a significant difference in performance.
분석 기사 • Apr 29H&R GmbH & Co. KGaA (ETR:2HRA) Shares Could Be 40% Below Their Intrinsic Value EstimateDoes the April share price for H&R GmbH & Co. KGaA ( ETR:2HRA ) reflect what it's really worth? Today, we will estimate...
Reported Earnings • Apr 24Full year 2020 earnings released: €0.24 loss per share (vs €0.037 loss in FY 2019)The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2020 results: Revenue: €878.5m (down 19% from FY 2019). Net loss: €9.02m (loss widened €7.65m from FY 2019). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 89 percentage points per year, which is a significant difference in performance.
분석 기사 • Mar 28H&R GmbH KGaA (ETR:2HRA) Has Debt But No Earnings; Should You Worry?David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
분석 기사 • Feb 04H&R GmbH KGaA's (ETR:2HRA) Shareholders Are Down 57% On Their SharesIt is a pleasure to report that the H&R GmbH & Co. KGaA ( ETR:2HRA ) is up 37% in the last quarter. But that is small...
Price Target Changed • Feb 03Price target raised to €6.65Up from €5.90, the current price target is an average from 2 analysts. The new target price is 9.4% above the current share price of €6.08. As of last close, the stock is up 16% over the past year.
Is New 90 Day High Low • Jan 21New 90-day high: €6.10The company is up 30% from its price of €4.71 on 23 October 2020. The German market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 22% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €1.12 per share.
Is New 90 Day High Low • Jan 05New 90-day high: €5.75The company is up 14% from its price of €5.03 on 07 October 2020. The German market is up 8.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 16% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €1.10 per share.
분석 기사 • Dec 13H&R GmbH KGaA (ETR:2HRA) Has Debt But No Earnings; Should You Worry?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Is New 90 Day High Low • Nov 27New 90-day high: €5.70The company is up 9.0% from its price of €5.22 on 28 August 2020. The German market is up 2.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 12% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €1.38 per share.
Analyst Estimate Surprise Post Earnings • Nov 17Revenue and earnings miss expectationsRevenue missed analyst estimates by 16%. Earnings per share (EPS) were also behind analyst expectations. Over the next year, revenue is forecast to grow 5.7%, compared to a 3.6% growth forecast for the Chemicals industry in Germany.
Reported Earnings • Nov 17Third quarter 2020 earnings released: €0.03 loss per shareThe company reported a decent third quarter result with reduced losses and improved control over expenses, although revenues were weaker. Third quarter 2020 results: Revenue: €213.3m (down 22% from 3Q 2019). Net loss: €1.21m (loss narrowed 80% from 3Q 2019). Over the last 3 years on average, earnings per share has fallen by 98% per year but the company’s share price has only fallen by 31% per year, which means it has not declined as severely as earnings.
Is New 90 Day High Low • Oct 15New 90-day low: €4.84The company is down 19% from its price of €5.97 on 17 July 2020. The German market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 7.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €1.46 per share.
공고 • Oct 05H&R Wasag AG to Report Fiscal Year 2009 Results on 03/30/2010H&R Wasag AG announced that they will report fiscal year 2009 results on 03/30/2010
Is New 90 Day High Low • Sep 26New 90-day low: €5.14The company is down 1.0% from its price of €5.21 on 26 June 2020. The German market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €1.44 per share.